Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 078886
Company: HETERO LABS LTD III
Company: HETERO LABS LTD III
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
EFAVIRENZ | EFAVIRENZ | 600MG | TABLET;ORAL | Prescription | AB | No | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/27/2018 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/078886_TA_PEPFAR_LTR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/06/2023 | SUPPL-27 | Labeling-Package Insert |
Label is not available on this site. |
EFAVIRENZ
TABLET;ORAL; 600MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
EFAVIRENZ | EFAVIRENZ | 600MG | TABLET;ORAL | Prescription | No | AB | 077673 | AUROBINDO PHARMA LTD |
EFAVIRENZ | EFAVIRENZ | 600MG | TABLET;ORAL | Prescription | No | AB | 204766 | CIPLA |
EFAVIRENZ | EFAVIRENZ | 600MG | TABLET;ORAL | Prescription | No | AB | 078886 | HETERO LABS LTD III |
EFAVIRENZ | EFAVIRENZ | 600MG | TABLET;ORAL | Prescription | No | AB | 204869 | STRIDES PHARMA |